Glancy, 65, said her decision to retire was difficult, but her health has been declining. She suffers from an inflamed sciatica nerve. “Years ago, it got better,” Glancy said. “But it’s back and I hope to get some relief with retiring.”
Convergence Pharmaceuticals' Novel Nav1.7 Selective Sodium Channel Blocker CNV1014802 Demonstrates Proof of Concept in Second Neuropathic Pain Study in Lumbosacral RadiculopathyPR NewswireCAMBRIDGE September 23 2014CAMBRIDGE September 23 2014 /PRNews
The ´Chronic Back Pain - Pipeline Review, H2 2014´, provides an overview of the Chronic Back Pain´s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Back Pain, complete with comparative ...
According to the Journal of Orthopedic and Sports Physical Therapy (JOSPT), up to 90% of pregnant women experience low back or pelvic pain during pregnancy. Some mothers find this pain goes away after the baby is born, however close to one third of these ...
Convergence Pharmaceuticals' Novel Nav1.7 Selective Sodium Channel Blocker CNV1014802 Demonstrates Proof of Concept in Second Neuropathic Pain Study in Lumbosacral RadiculopathyPR NewswireCAMBRIDGE September 23 2014CAMBRIDGE September 23 2014 /PRNews
No comments:
Post a Comment